Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1362 studies found for:    "Liver Neoplasms"
Show Display Options
Rank Status Study
21 Completed Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed
Condition: Liver Cancer
Interventions: Biological: recombinant interferon alfa;   Drug: thalidomide
22 Terminated
Has Results
Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Condition: Liver Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: sunitinib malate;   Other: laboratory biomarker analysis;   Procedure: hepatic artery embolization;   Procedure: quality-of-life assessment
23 Completed Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer
Conditions: Liver Cancer;   Metastatic Cancer
Interventions: Drug: isolated perfusion;   Drug: melphalan
24 Completed A Phase I Study of Pazopanib in Adult Patients With Liver Cancer
Conditions: Carcinoma, Hepatic Cell;   Liver Cancer
Intervention: Drug: pazopanib
25 Completed Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases
Conditions: Liver Cancer;   Metastatic Cancer
Intervention: Procedure: cryosurgery
26 Terminated Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients
Conditions: Liver Neoplasms;   Liver Cirrhosis;   Carcinoma, Hepatocellular;   Recurrence;   Neoplasm Recurrence, Local
Intervention: Drug: Oxaliplatin, gemcitabine, cisplatin, lipiodol
27 Terminated
Has Results
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
Conditions: Liver Cancer;   Metastatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: computed tomography;   Procedure: magnetic resonance imaging;   Procedure: positron emission tomography;   Procedure: radiofrequency ablation;   Procedure: radionuclide imaging;   Procedure: ultrasound imaging;   Radiation: fludeoxyglucose F 18 (FDG-PET);   Radiation: gadopentetate dimeglumine
28 Recruiting Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
Condition: Liver Cancer
Intervention: Drug: Lipiodol
29 Completed
Has Results
An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer
Conditions: Liver Neoplasms;   Unresectable Hepatocellular Carcinoma
Intervention: Drug: Sunitinib (SU011248)
30 Completed Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer
Condition: Liver Cancer
Interventions: Drug: alvocidib;   Drug: irinotecan hydrochloride
31 Completed Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
Condition: Liver Cancer
Intervention: Drug: arsenic trioxide
32 Active, not recruiting Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Conditions: Breast Cancer;   Colorectal Cancer;   Gastric Cancer;   Liver Cancer;   Melanoma (Skin);   Metastatic Cancer;   Ovarian Cancer;   Pancreatic Cancer
Interventions: Drug: cyclophosphamide;   Drug: poly ICLC;   Procedure: hepatic artery embolization;   Radiation: 3-dimensional conformal radiation therapy
33 Active, not recruiting Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Condition: Hepatocellular Cancer
Interventions: Drug: Sorafenib;   Procedure: Radiofrequency Ablation
34 Completed Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer
Conditions: Liver Cancer;   Metastatic Cancer
Intervention:
35 Completed Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
Conditions: Carcinoma, Hepatocellular;   Liver Neoplasms
Intervention: Device: yttrium Y 90 microspheres (TheraSphere®)
36 Withdrawn Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases
Conditions: Metastatic Liver Cancer;   Secondary Liver Cancer;   Liver Neoplasm
Interventions: Device: Radiofrequency Ablation (RFA);   Drug: Chemotherapy
37 Completed
Has Results
Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial
Condition: Liver Cancer
Intervention: Drug: lenalidomide
38 Completed A Retrospective Review of Malignant Liver Tumors
Condition: Liver Cancer
Intervention:
39 Unknown  Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Condition: Liver Cancer
Interventions: Drug: doxorubicin-eluting beads;   Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies;   Other: pharmacological study;   Procedure: quality-of-life assessment
40 Completed Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Biological: bevacizumab;   Other: laboratory biomarker analysis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years